Skip To Content

Resources

Sherry Myles
This document provides an overview of the ACD/pKa Classic prediction model and a review of improvements in prediction accuracy including highlights of collaborative projects using proprietary customer data, with excellent results.

Sherry Myles
ACD/Labs and MilliporeSigma Expand Partnership to Advance Digital, Sustainable Compound Verification & Quantification by NMR and IR Toronto, CANADA (May 22, 2025)—ACD/Labs is pleased to expand its partnership with MilliporeSigma (the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany), building on the 2023 collaboration that launched the first digital reference material (dRM)...

Sherry Myles
Stability decisions in pharmaceutical development require extensive data, often scattered across incompatible systems. For scientists, this complicates analysis, increases errors, and hinders collaboration. Luminata® streamlines forced degradation and accelerated predictive stability (APS) studies by consolidating data into a chemically intelligent platform, enabling efficient analysis and informed decision-making. See how Luminata accelerates and simplifies stability workflows...

Sherry Myles
ChemSketch is the primary software module for many ACD/Labs programs and can be used to create reports with your spectral data (including NMR, LC/MS, and UV-IR). The software supports report templates for our specialized solutions such as Katalyst D2D, MetaSense, and Luminata; highlighting is applicability across different fields. ChemSketch allows users to produce high-quality figures...